State firm working on insulin deliverer

Fayetteville-based SFC Fluidics Inc. is working with JDRF, the world’s leading organization funding research into Type 1 diabetes, to develop a small, automated insulin delivery device.

The Industry Development and Discovery Partnership is a 2-year funding commitment to build on SFC Fluidics existing technology to develop a next generation automated insulin delivery device. The tiny device will deliver doses of insulin and contain an integrated continuous glucose monitor in a single pod that can be disposed of every three days, according to a Monday release.

Type 1 diabetes is an autoimmune disease in which insulin-producing beta cells in the pancreas are mistakenly destroyed by the body’s immune system, according to the JDRF website. There is currently no cure and those with Type 1 diabetes are dependent on injected or pumped insulin to survive.

“There has been tremendous progress in the development of CGM devices and closed loop algorithms. However, the integration of a pump, a CGM and an algorithm into a single, convenient pod that reduces the on-body burden for the patient has not been successfully addressed,” Anthony Cruz, CEO of SFC Fluidics, said in a statement.

SFC Fluidics is a VIC Technology Venture Development portfolio company. Fayetteville-based VIC has 14 portfolio companies in fields that include nanotechnology, cancer diagnostics, pharmaceuticals and semiconductors.